2 November 2021

On Friday 29 October 2021, during the 18th European AIDS Conference in London, the Hector Research Award for the best scientific article related to clinical or epidemiological HIV research was presented to Angela Colbers and David Burger, both working in the Pharmacy of the RadboudUMC.

The article in question, entitled "Simplified dolutegravir dosing for children with HIV weighing 20kg or more: pharmacokinetic and safety substudies of the multicentre, randomized ODYSSEY trial" was published in 2020 in Lancet HIV with hospital pharmacist/researcher-in-charge Pauline Bollen as 1st author.

The jury gave, as justification for the selection of this article, the great importance of pharmacokinetics studies in this subpopulation of HIV-positive children, who, especially in Africa, often cannot obtain suitable formulations for adequate HIV treatment. This research has now made this possible, and by now, many African countries have already set up programs to have HIV-positive children treated with these new doses of dolutegravir. Also, the studied doses are now included in the WHO guidelines for treatment of children with HIV.

The prize consists of a certificate and an amount of 10,000 €.

  • Want to know more about these subjects? Click on the buttons below for more news.


Related news items

Rob Aarnoutse is appointed as professor in Translation pharmacology of antimicrobial agents in particular drugs for tuberculosis

25 January 2021 Hospital pharmacist and clinical pharmacologist Rob Aarnoutse is appointed as professor in ‘Translation pharmacology of antimicrobial agents, in particular drugs for tuberculosis’ at Radboud University / Radboudumc, starting 16 November 2020. read more

Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2)

12 May 2020 In Lancet HIV RIHS researchers Angela Colbers and David Burger showed in an open-label, randomized controlled trial, that, when initiated in the 3rd trimester of pregnancy, achievement of VL <50cp/mL at delivery was more likely with dolutegravir-based therapy than with efavirenz-based regimens. read more

The effect of pregnancy on the pharmacokinetics of dolutegravir in women living with HIV

17 March 2020 In Clinical infectious diseases RIHS researchers Pauline Bollen, Jolien Freriksen, Angela Colbers and David Burger together with researchers of the PANNA network showed that dolutegravir use in pregnancy results in effective plasma concentrations. read more

Importance of prospective studies in pregnant and breastfeeding women living with HIV

14 March 2019 In Clinical Infectious Diseases Angela Colbers, Stein Schalkwijk and David Burger give considerations on how to effectively evaluate aspects of clinical pharmacology required for safe and effective treatment to optimize pharmacotherapy during pregnancy and breastfeeding. read more

Beyond the scientist: Roger Brüggemann

13 November 2018 Roger, who subscribed for the national pilot academy in 1992, eventually became a hospital pharmacist and associate professor of clinical pharmacology. This summer he became a “Cinglé du Ventoux”. read more

Pharmacy receives prestigious European prize for research in Africa

27 September 2018 On 17 September, David Burger, professor of clinical pharmacy, together with colleagues from the United Kingdom, Uganda and Zimbabwe, received the "Outstanding Research Team" award from the European - Developing Countries Clinical Trial Partnership (EDCTP). read more